Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Investors Should Be Careful Around AstraZeneca plc

| Rupert Hargreaves

With opposition against the Pfizer-AstraZeneca plc (LON: AZN) deal growing, investors need to be careful.

Read more »

Investing Articles

How AstraZeneca plc Could Struggle To Repeat A 5-Year Gain of 78%

| G A Chester

AstraZeneca plc (LON:AZN) could loose a third of its value in the next five years.

Read more »

Investing Articles

AstraZeneca plc Is In Play And I’m Holding Out For More

| Malcolm Wheatley

What might be the impact on your wealth if Pizfer buys AstraZeneca plc (LON:AZN)?

Read more »

Investing Articles

What Could Pfizer-AstraZeneca Be Like?

| Prabhat Sakya

What might be the positives from this potential takeover?

Read more »

Company Comment

Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning?

| Mark Stones

AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE)

Read more »

Investing Articles

Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’?

| Lisa Walls-Hester

Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it…

Read more »

Investing Articles

What Dividend Hunters Need To Know About AstraZeneca plc

| Royston Wild

Royston Wild looks at whether AstraZeneca plc (LON: AZN) is an attractive income stock.

Read more »

Investing Articles

AstraZeneca plc CEO’s Sweet Spot

| Alessandro Pasetti

AstraZeneca plc (LON:AZN) CEO Pascal Soriot should ask for more because Pfizer Inc. (NYSE:PFE) could go hostile...

Read more »

Investing Videos

What Should You Do With Your AstraZeneca plc Shares?

| Nate Weisshaar

VIDEO: Two Fools put AstraZeneca plc (LON:AZN) under the spotlight.

Read more »

Investing Articles

Could Shire PLC And Hikma Pharmaceuticals Plc Be The Next Pharma Takeover Targets?

| G A Chester

AstraZeneca plc (LON:AZN) is in play, and Shire PLC (LON:SHP) and Hikma Pharmaceuticals Plc (LON:HIK) now look ripe for bids.

Read more »

Investing Articles

3 Numbers That Don’t Lie About The AstraZeneca plc Takeover Offer

| Roland Head

Roland Head looks beneath the surface of Pfizer's £50 per share takeover offer for AstraZeneca plc (LON: AZN). Was AstraZeneca…

Read more »

Investing Articles

Boost Your Pharma Income By 170%: Sell AstraZeneca plc Today And Buy GlaxoSmithKline plc

| Roland Head

How AstraZeneca plc (LON:AZN) shareholders could lock in a massive income boost by switching to GlaxoSmithKline plc (LON:GSK).

Read more »